The company’s first product, the SuperMethyl™ Fast Bisulfite Conversion Kit was launched at the Chicago Biomedical Consortium’s Chicago BioCapital Summit. This advanced kit achieves over 99.5% methyl ...

The Microarray segment dominated the market and accounted for a share of 41.29% in 2024. Bisulfite genomic sequencing is related to a technology of a higher standard. To investigate the epigenetic ...

We integrate 3D cell culture systems of primary human cells, microfluidics and comprehensive molecular profiling technologies to discover novel therapeutic strategies for inflammatory conditions (NASH ...